CASI PHARMACEUTICALS, INC. Finite-Lived Intangible Asset, Expected Amortization, Year Five
CASI PHARMACEUTICALS, INC. had Finite-Lived Intangible Asset, Expected Amortization, Year Five of $5.00 thousand as of 2022-12-31, per its 20-F filed 2023-04-26.
Discontinued › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive · last filed 2023-04-26
- 2022-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five $5.00K.
- 2021-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five $1.32M.
- 2020-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five $1.29M.
- 2019-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five $1.50M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year Five |
|---|---|
| 2022-12-31 | $5.00K 20-F · filed 2023-04-26 |
| 2021-12-31 | $1.32M 10-K · filed 2022-03-28 |
| 2020-12-31 | $1.29M 10-K · filed 2021-03-30 |
| 2019-12-31 | $1.50M 10-K · filed 2020-03-16 |
| 2019-09-30 | $1.53M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $1.58M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $1.54M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $1.55M 10-K · filed 2019-03-29 |
| 2018-09-30 | $1.39M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $1.39M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $1.39M 10-Q · filed 2018-05-15 |